Dr. Karsten Eastman is the co-founder and CEO of Sethera Therapeutics, a pioneering therapeutics platform company leveraging processes to unlock previously undruggable targets. With a Ph.D. from the University of Utah under Professor Vahe Bandarian, Dr. Eastman has developed methodologies that challenge long-standing scientific dogmas in peptide and enzyme engineering. They have led Sethera from inception, securing multimillion-dollar funding, and advancing a pipeline of bespoke peptides with applications across multiple therapeutic areas. Dr. Eastman is dedicated to integrating AI-driven discovery with enzymatic processes to reshape drug development and expand the possibilities of molecular design.